Skip to main content

Peninsula Capital Invests In Zadig & Voltaire

Private equity investor Peninsula Capital has taken a minority stake in French luxury goods company Zadig & Voltaire. The firm will remain majority-owned by its Founder, Thierry Gillier, who remains as Chairman of the company. Zadig gets a new CEO, Remy Baume, who is also becoming a shareholder.

Stefano Marsaglia, Co-Founder and Managing Partner at Peninsula, said, “We have closely followed the development of Zadig & Voltaire for a long time, and we are delighted to partner with Thierry Gillier, Cecilia Bonstrom, Remy Baume and the entire management team. Thierry’s vision has driven Zadig & Voltaire from its creation to becoming one of the leading French modern luxury brands, and we share his ambitions. We look forward to contributing to the future success of Zadig & Voltaire, and to leverage our retail expertise and global network to help the company achieve its full potential. This transaction marks the entry of Peninsula in France, and we are glad to make this investment in a company with such a unique brand with tremendous growth opportunities worldwide.”

Boston-based private equity shop TA Associates was the previous minority partner, and is exiting the investment.

Patrick Sader, Managing Director at TA Associates, said, "We are very pleased to have assisted Zadig & Voltaire with its international development. Our partnership with Thierry Gillier perfectly illustrates TA Associates' minority investment philosophy. We thank Thierry for his exceptional leadership and commitment, and Artistic Director Cecilia Bonstrom for her unwavering dedication to creativity and quality. We believe that Zadig & Voltaire is a timeless brand with tremendous appeal that is uniquely positioned to benefit from further growth. We wish them continued success.”

Deloitte served as financial advisor, and Linklaters and Van Campen Liem served as legal counsel to Peninsula. Terms of the deal were not disclosed.

© The Sortino Group Ltd

All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.